Specifically, in vivo, the intracutaneous injection of CCL27 attracted lymphocytes, and conversely, the neutralization of CCL27–CCR10 interactions inhibited lymphocyte trafficking to the skin, leading to the suppression of allergen-induced skin inflammation [87]. Here, CCL27 is linked to dermatitis.